1) ginsenoside Rg_1 and Rh_1
人参皂苷Rg1、Rh1
3) ginsenoside Rg_1
人参皂苷Rg1
1.
Methods:The extraction rate of ginsenoside Rg_1 and the content of ferulic acid were used as the indices of evaluation,respectively,the extraction of Radix Notoginseng and the Purification of Rhizoma Chuanxiong and others were optimized by orthogonal tests.
方法:分别以人参皂苷Rg1提取率和阿魏酸含量为考察指标,采用正交试验法对三七提取工艺及川芎等药材的醇沉工艺进行优化。
2.
Methods The amount of ginsenoside Rg_1 content was adopted to evaluate the fermentation indexes,and the L_9(34) orthogonal design experiment was adopted to screen the superior fermentation technological contidions.
方法以发酵物中人参皂苷Rg1含量为评价发酵工艺的指标,采用L9(34)正交设计试验筛选较优的发酵工艺条件。
3.
The cotnents of ginsenoside Rg_1 and ginsenoside Re in ginseng were determined by HPLC.
方法采用正交试验法进行优选,高效液相色谱法测定人参皂苷Rg1和人参皂苷Re的含量。
4) Ginsenoside Rg1
人参皂苷Rg1
1.
Effect of ginsenoside Rg1 on long-term potentiation impaired by lead in CA1 region of rat hippocampus;
人参皂苷Rg1对铅所致大鼠海马CA1区长时程增强损伤的影响(英文)
2.
Effects of ginsenoside Rg1 on angiogenesis and VEGF expression in rats with acute myocardial infarction;
人参皂苷Rg1对急性心肌梗死大鼠血管新生的作用
3.
Neuroprotective effect of ginsenoside Rg1 on dopaminergic neurons and blocking effect of ICI182,780;
人参皂苷Rg1对多巴胺能神经元的保护作用及ICI182,780的阻断作用
5) ginsenoside Rg 1
人参皂苷Rg1
1.
Objective: To study the influence of the sustai ne d release excipient on the release rate of ginsenoside Rg 1 and ginsenoside Rb 1 in sustained-release tablet of Panax Notoginsenosides.
目的 :探讨缓释辅料对三七总皂苷缓释片中人参皂苷Rg1,Rb1释药特性的影响。
2.
AIM: To establish for the content determination of ginsenoside Rg 1 and ginsenoside Rb 1 in Tianqitongjing Capsule (Radix Notoginsing, Excrementum Trogopteri seu Pteromydis, etc.
目的:建立用HPLC法测定田七痛经胶囊(三七,五灵脂,蒲黄等)中人参皂苷Rb1、人参皂苷Rg1 的含量。
3.
Objective To establish the HPLC method for the determination of ginsenoside Rg 1 and ginsenoside Re in the Xiongdanjiuxin Dropping Pills.
目的建立熊胆救心滴丸中人参皂苷Rg1和人参皂苷Re的含量测定方法。
补充资料：人参皂苷 Rg1
分子式：C42H72O14
分子量：801.01
CAS号：22427-39-0
性质：
分子量：801.01
CAS号：22427-39-0
性质：
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条